WuXi Biologics spinning off WuXi XDC
WuXi Biologics is an international CRDMO in the field of biopharmaceutics. It has recently proposed a spin-off of its crown jewel, WuXi XDC.
M3: Medicine, Media, Metamorphosis
We believe that M3 sits at the intersection of the medical and digitalization software industry.
Tough times for Singapore offshore REITs
With the increase in interest rates globally, cracks are starting to surface in commercial real estate. Real Estate Investment Trusts (REITs) have been key to Singapore’s capital markets, and in the last couple of years, there have been more REITs seeking overseas assets. A result of this trend is
L'Oreal to fuel Aesop expansion in China
Sitting in L’Oreal Luxe portfolio, the brand positioning looks set to fuel the next phase of growth for Aesop into a billion-dollar-sales business. Entry into China and travel retail is likely going to be a cornerstone of the strategy.
Reebok Catalyst charts a new path for FARFETCH
In the heart of Milan along Via Turati, a newly-assembled team is looking to reposition Reebok as the next luxury brand.